Cunzhen Zhang
Kexue Road
Zhengzhou, 450001, China
Zhengzhou, 450001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Research on the content and activity of CYP450 enzymes in human liver.
Journal: Drug metabolism reviews
Published: September 30, 2025
Chlorzoxazone-based One-Sample Method for Estimating In Vivo CYP2E1 Activity in Mice.
Journal: Current drug metabolism
Published: June 04, 2025
Cytochrome P450 2E1 inhibitor Q11 is effective on hepatocellular carcinoma by promoting peritumor neutrophil chemotaxis.
Journal: International journal of biological macromolecules
Published: October 24, 2024
Q11, a CYP2E1 inhibitor, exerts anti-hepatocellular carcinoma effect by inhibiting M2 macrophage polarization.
Journal: Cancer immunology, immunotherapy : CII
Published: October 20, 2024
Identification of Hepatocellular Carcinoma Subtypes Based on Global Gene Expression Profiling to Predict the Prognosis and Potential Therapeutic Drugs.
Journal: Biomedicines
Published: September 30, 2024
Identification of Cytochrome P450 2E1 as a Novel Target in Glioma and Development of Its Inhibitor as an Anti-Tumor Agent.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 17, 2023
The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics.
Journal: Journal of translational medicine
Published: November 01, 2021
Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarker.
Journal: Journal of translational medicine
Published: July 07, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026